Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of the Rheumatic Diseases|July 31, 2012
Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptideSarah E Wythe, Danielle DiCara, Taher E I Taher, et al.Arthritis and Rheumatism|September 29, 2011
Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritisPanagiotis Kamperidis, Tahereh Kamalati, Mathieu Ferrari, et al.Arthritis and Rheumatism|February 5, 2010
Human single-chain variable fragment that specifically targets arthritic cartilageChris Hughes, Bjarne Faurholm, Francesco Dell'Accio, et al.Plos One|September 28, 2013
Increased neurofilament light chain blood levels in neurodegenerative neurological diseasesJohanna Gaiottino, Niklas Norgren, Ruth Dobson, et al.Diabetes/Metabolism Research and Reviews|July 26, 2016
Autoantibodies to post-translationally modified type I and II collagen in Charcot neuroarthropathy in subjects with type 2 diabetes mellitusPaola Rizzo, Dario Pitocco, Francesco Zaccardi, et al.Frontiers in Immunology|March 3, 2020
Targeting Extracellular Vesicles to the Arthritic Joint Using a Damaged Cartilage-Specific AntibodyLouise M Topping, Bethan L Thomas, Hefin I Rhys, et al.Biochemical Society Transactions|September 23, 2011
Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint diseasePaul G Winyard, Brent Ryan, Paul Eggleton, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 18, 2014
Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcomeJens Kuhle, Johanna Gaiottino, David Leppert, et al.Arthritis and Rheumatism|April 12, 2013
Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritisRocky Strollo, Frederique Ponchel, Vivianne Malmström, et al.Diabetologia|October 7, 2022
Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetesRocky Strollo, Chiara Vinci, Y K Stella Man, et al.Pageof 3